Peter C. Brandt
Chief Executive Officer, NOVEN PHARMACEUTICALS INC.
Companies
- IN8BIO, INC.Board member Jul 29, 2021 to now1
- Opus Genetics, Inc.Board member Oct 6, 2010 to Jun 7, 20192
- EpocratesBoard member Feb 1, 2011 to Mar 13, 20133
- EpocratesChief executive officer Dec 9, 2011 to Dec 9, 20114
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- IN8BIO, INC. INAB98,690 shares5$116.9K at $1.19Dec 23, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 22, 2025Granted 72,464 shares at $1.38 of IN8BIO, INC.5
- Apr 30, 2025Exercised options 81,967 shares at $0.18 of IN8BIO, INC.6
- Apr 30, 2025Exercised options 81,967 shares at $0.18 of IN8BIO, INC.6
- Oct 4, 2024Granted 253,164 shares of IN8BIO, INC.7
- Dec 13, 2023Granted 81,967 shares of IN8BIO, INC.8
- Aug 16, 2022Bought 105,263 shares at $1.90 of IN8BIO, INC.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARIN8BIO, INC., Board member
- 2SEC EDGAROpus Genetics, Inc., Board member
- 3SEC EDGAREpocrates, Board member
- 4SEC EDGAREpocrates, Chief executive officer
- 5
- 6SEC EDGARForm 4 filed May 7, 2025
- 7SEC EDGARForm 4 filed Oct 8, 2024
- 8SEC EDGARForm 4 filed Dec 15, 2023
- 9SEC EDGARForm 4 filed Aug 18, 2022